Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders

Journal of Neurochemistry

Volumn 112, Issue 5, 2010, Pages 1099-1114

  Von Bernhardi, Rommy ^a   Tichauer, Juan E ^a   Eugenín, Jaime ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Cytokines; Cytotoxicity; Glial cells; Inflammation; Senescence; Transforming growth factor 1

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVATION; CELL AGING; CELL FUNCTION; CELL STRUCTURE; COGNITIVE DEFECT; CYTOKINE RELEASE; CYTOTOXICITY; DEGENERATIVE DISEASE; DNA DAMAGE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; INFLAMMATION; MICROGLIA; MOLECULAR BIOLOGY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; TELOMERE; TUMOR SUPPRESSOR GENE;

AGING; ANIMALS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; IRON; MICROGLIA; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 75949127404     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06537.x     Document Type: Review

References (204)

1. Adler A. S., Sinha S., Kawahara T. L., Zhang J. Y., Segal E. Chang H. Y. (2007) Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 21, 3244 3257.
2. Adler A. S., Kawahara T. L., Segal E. Chang H. Y. (2008) Reversal of aging by NFkappaB blockade. Cell Cycle 7, 556 559.
3. Akiyama H., Barger S., Barnum S. et al. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383 421.
4. Apelt J. Schliebs R. (2001) Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 894, 21 30.
5. Arriagada P. V., Marzloff K. Hyman B. T. (1992) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42, 1681 1688.
6. Barja G. (1999) Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J. Bioenerg. Biomemb. 31, 347 366.
7. von Bernhardi R. (2007) Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox. Res. 12, 215 232.
8. von Bernhardi R. (2009) Immunotherapy in Alzheimer Disease: where do we stand? Where should we go? J. Alzheimer Dis. [Epub ahead of print] doi :.
9. von Bernhardi R. Eugenín J. (2004) Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res. 1025, 186 193.
10. von Bernhardi R. Ramírez G. (2001) Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system? Biol. Res. 34, 123 128.
11. Blasko I., Apochal A., Boeck G., Hartmann T., Grubeck-Loebenstein B. Ransmayr G. (2001) Ibuprofen decreases cytokine induced amyloid beta production in neuronal cells. Neurobiol. Dis. 8, 1094 1101.
12. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P. Grubeck-Loebenstein B. (2004) How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 3, 169 176.
13. Blennow K., de Leon M. J. Zetterberg H. (2006) Alzheimer's disease. Lancet 368, 387 403.
14. Block M. L., Zecca L. Hong J. S. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. 8, 57 69.
15. Boche D., Cunningham C., Docagne F., Scott H. Perry V. H. (2006) TGFbeta1 regulates the inflammatory response during chronic neurodegeneration. Neurobiol. Dis. 22, 638 650.
16. Bondareff W. Geinisman Y. (1976) Loss of synapses in the dentate gyrus of the senescent rat. Am. J. Anat. 145, 129 136.
17. Broe G. A., Grayson D. A., Creasey H. M., Waite L. M., Casey B. J., Bennett H. P., Brooks W. S. Halliday G. M. (2000) Anti-inflammatory drugs protect against Alzheimer's disease at low doses. Arch. Neurol. 57, 1586 1591.
18. Brunk U. T. Terman A. (2002) The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. 269, 1996 2002.
19. Bye N., Zieba M., Wreford N. G. Nichols N. R. (2001) Resistance of the dentate gyrus to induced apoptosis during ageing is associated with increases in transforming growth factor-beta 1 messenger RNA. Neuroscience 105, 853 862.
20. Byrnes K. R., Loane D. J. Faden A. L. (2009) Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics 6, 94 107.
21. Cagnin A., Brooks D. J., Kennedy A. M., Gunn R. N., Myers R., Rurkheimer F. E., Jones T. Banati R. B. (2001) In vivo measurement of activated microglia in dementia. Lancet 358, 461 467.
22. Cañuelo A., Siles E., Martínez-Romero R., Peinado M. A. Martínez-Lara E. (2007) The nitric oxide system response to hypoxia/reoxygenation in the aged cerebral cortex. Exp. Gerontol. 42, 1137 1145.
23. Carlsson A. (1987) Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups. Gerontology 33, 159 167.
24. Carmen J., Gowing G., Julien J. P. Kerr D. (2006) Altered immune response to CNS viral infection in mice with a conditional knock-down of macrophage-lineage cells. Glia 54, 71 80.
25. Carson M. J., Bilousova T. V., Puntambekar S. S., Melchior B., Doose J. M. Ethell I. M. (2007) A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease Neurotherapeutics 4, 571 579.
26. Chalazonitis A., Kalberg J., Twardzik D. R., Morrison R. S. Kessler J. A. (1992) Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor. Dev. Biol. 152, 121 132.
27. Chen S., Luo D., Strit W. Harrison J. K. (2002) TGF-β1 up regulates CX3CR1 expression and inhibits ractalkin stimulated signaling in rat microglia. J. Neuroimmunol. 133, 46 55.
28. Colangelo V., Schurr J., Ball M. J., Pelaez R. P., Bazan N. G. Lukiw W. J. (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462 473.
29. Combs C. K., Karlo J. C., Kao S. C. Landreth G. E. (2001) Beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179 1188.
30. Conde J. R. Streit W. J. (2006a) Effect of aging on the microglial response to peripheral nerve injury. Neurobiol. Aging 27, 1451 1461.
31. Conde J. R. Streit W. J. (2006b) Microglia in the aging brain. J. Neuropathol. Exp. Neurol. 65, 199 203.
32. Connor J. R., Menzies S. L., St. Martin S. M. Mufson E. J. (1990) Cellular distribution of transferrin, ferritin and iron in normal and aged human brains. J. Neurosci. Res. 27, 595 611.
33. Connor J. R., Snyder B. S., Arosio P., Loeffler D. A. LeWitt P. (1995) A quantitative analysis of isoferritins in select regions of aged, Parkinsonian and Alzheimer disease brains. J. Neurochem. 65, 717 724.
34. Coraci I. S., Husemann J., Berman J. W., Hulette C., Dufour J. H., Campanella G. K., Luster A. D., Silverstein S. C. El-Khoury J. B. (2002) CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 160, 101 112.
35. Cunningham C., Wilcockson D. C., Campion S., Lunnon K. Perry V. H. (2005) Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25, 9275 9284.
36. Cunningham C., Campion S., Lunnon K., Murray C. L., Woods J. F., Deacon R. M., Rawlins J. N. Perry V. H. (2009) Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 65, 304 312.
37. Davis D. G., Schmitt F. A., Wekstein D. R. Markesbery W. R. (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J. Neuropath. Exp. Neurol. 58, 376 388.
38. DeWitt D. A., Perry G., Cohen M., Doller C. Silver J. (1998) Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149, 329 340.
39. Dhandapani K. M., Hadman M., De Sevilla L., Wade M. F., Mahesh V. B. Brann D. W. (2003) Astrocyte protection of neurons. Role of transforming growth factor-β signaling via c-jun-Ap-1 protective pathway. J. Biol. Chem. 278, 43329 43339.
40. Dik M. G., Jonker C., Hack C. E., Smit J. H., Comijs H. C. Eikelenboom P. (2005) Serum inflammatory proteins and cognitive decline in older persons. Neurology 64, 1371 1377.
41. Dilger R. N. Johnson R. W. (2008) Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J. Leukoc. Biol. 84, 932 939.
42. Drachman D. A. (2006) Aging of the brain, entropy, and Alzheimer disease. Neurology 67, 1340 1352.
43. Driscoll I., Davatzikos C., An Y., Wu X., Shen D., Kraut M. Resnick S. M. (2009) Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 72, 1906 1913.
44. Dröge W. Schipper H. M. (2007) Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6, 361 370.
45. Duan H., Wearne S. L., Rocher A. B., Macedo A., Morrison J. H. Hof P. R. (2003) Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb. Cortex 13, 950 961.
46. Dziedzic T., Wybranska I., Dembinska-Kiec A., Klimkowicz A., Slowik A., Pankiewicz J., Adzienicka A. Szczudlik A. (2003) Dexamethasone inhibits TNF-alpha synthesis more effectively in Alzheimer's disease patients than in healthy individuals. Dement. Geriatr. Cogn. Disord. 16, 283 286.
47. Ebert S., Gerber J., Bader S., Muhlhauser F., Brechtel K., Mitchell T. J. Nau R. (2005) Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination. J. Neuroimmunol. 159, 87 96.
48. Eichhoff G., Busche M. A. Garaschuk O. (2008) In vivo calcium imaging of the aging and diseased brain. Eur. J. Nucl. Med. Mol. Imaging 35 (Suppl. 1 S99 106.
49. Etminan M., Gill S. Samii A. (2003) Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 327, 128 131.
50. Eyüpoglu L. Y., Bechmann L. Nitsch R. (2003) Modification of microglial function protects from lesion-induced neuronal alteration and promotes sprouting in the hippocampus. FASEB J. 17, 1110 1111.
51. Fiala M., Lin J., Ringman J. et al. (2005) Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J. Alzheimers Dis. 7, 221 232 discussion 255-262.
52. Floden A. M. Combs C. K. (2006) Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J. Neurosci. 26, 4644 4648.
53. Forster M. J., Dubey A., Dawson K. M., Stutts W. A., Lal H. Sohal R. S. (1996) Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. U S A 93, 4765 4769.
54. Fortun A., Khalil A., Gagné D., Douziech N., Kuntz C., Jay-Gerin J. P., Dupuis G. Fülöp T., Jr. (2001) Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 156, 11 21.
55. Fraga M. F. Esteller M. (2007) Epigenetics and aging: the targets and the marks. Trends Genet. 23, 413 418.
56. Fraga M. F., Ballestar E., Paz M. F. et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U S A 102, 10604 10609.
57. Fujimura M., Usuki F., Sawada M. Takashima A. (2009) Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. Neurotoxicology 30, 1000 1007.
58. Garg T. K. Chang J. Y. (2006) Methylmercury causes oxidative stress and cytotoxicity in microglia: attenuation by 15-deoxy-delta 12,14-prostaglandin J2. J. Neuroimmunol. 171, 17 28.
59. Geinisman Y., de Toledo-Morrell L. Morrell F. (1986) Loss of perforated synapses in the dentate gyrus: morphological substrate of memory deficit in aged rats. Proc. Natl. Acad. Sci. U S A 83, 3027 3031.
60. Geula C., Wu C. K., Saroff D., Lorenzo A., Yuan M. Yankner B. A. (1998) Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat. Med. 4, 827 831.
61. Giunta S. (2006) Is inflammaging an auto[innate]immunity subclinical syndrome? Immun. Ageing 3 12 doi :.
62. Glezer I., Simard A. R. Rivest S. (2007) Neuroprotective role of the innate immune system by microglia. Neuroscience 147, 867 883.
63. Godbout J. P. Johnson R. W. (2004) Interleukin-6 in the aging brain. J. Immunol. 147, 141 144.
64. Godbout J. P., Chen J., Abraham J., Richwine A. F., Berg B. M., Kelley K. W. Johnson R. W. (2005) Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 19, 1329 1331.
65. Gomez C. R., Nomellini V., Faunce D. E. Kovacs E. J. (2008) Innate immunity and aging. Exp. Gerontol. 43, 718 728.
66. Gordon S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23 35.
67. Gosche K. M., Mortimer J. A., Smith C. D., Markesbery W. R. Snowdon D. A. (2002) Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology, 58, 1476 1482.
68. Grathwohl S. A., Kälin R. E., Bolmont T. et al. (2009) Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia. Nat. Neurosci. 12, 1358 1360.
69. Griffin W. S. Mrak R. E. (2002) Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukoc. Biol. 72, 233 238.
70. Hanisch U. K. (2002) Microglia as a source and target of cytokines. Glia 40, 140 155.
71. Harry G. J., Lefebvre d'Hellencourt C., Bruccoleri A. Schmechel D. (2000) Age-dependent cytokine responses: trimethyltin hippocampal injury in wild-type, APOE knockout, and APOE4 mice. Brain Behav. Immun. 14, 288 304.
72. Hashimoto M., Takeda A., Hsu L. J., Takenouchi T. Masliah E. (1999) Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease. J. Biol. Chem. 274, 28849 28852.
73. Hayashi Y., Yoshida M., Yamato M. et al. (2008) Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J. Neurosci. 28, 8624 8634.
74. Hayashida T., Decaestecker M. Schnaper W. (2004) Cross-talk between ERK MAP kinase and Smad signaling pathways TGF-β dependent response in human mesangial cells. FASEB J. 17, 1576 1578.
75. Herrera-Molina R. von Bernhardi R. (2005) Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiol. Dis. 19, 229 236.
76. Hickman S. E., Allison E. K. El Khoury J. (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28, 8354 8360.
77. Hirose W., Ikematsu K. Tsuda R. (2003) Age-associated increase in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg. Med. 5 (Suppl. 1 S360 S366.
78. Ho L., Purohit D., Haroutinian V., Luterman J. D., Willis F., Naslund J., Buxbaum J. D., Mohs R. C., Aisen P. S. Pasinetti G. M. (2001) Neuronal cyclooxigenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch. Neurol. 58, 487 492.
79. Hof P. R. Morrison J. H. (2004) The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci. 27, 607 613.
80. Holmes C., El-Okl M., Williams A. L., Cunningham C., Wilcockson D. Perry V. H. (2003) Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 74, 788 789. (Pubitemid 36628295)
81. Howard L. M., Miga A. J., Vanderlugt C. L., Dal Canto M. C., Laman J. D., Noelle R. J. Miller S. D. (1999) Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103, 281 290.
82. Husemann J., Loike J. D., Anankov R., Febbraio M. Silverstein S. C. (2002) Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40, 195 205.
83. Ishida Y., Kondo T., Takayasu T., Iwakura Y. Mukaida N. (2004) The essential involvement of cross-talk between IFN-γ and TGF-β1 in the skin wound-healing process. J. Immunol. 172, 1848 1855.
84. Jacobs B., Driscoll L. Schall M. (1997) Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J. Comp. Neurol. 386, 661 680.
85. Jesko H., Chalimoniuk M. Strosznajder J. B. (2003) Activation of constitutive nitric oxide synthase(s) and absence of inducible isoform in aged rat brain. Neurochem. Int. 42, 315 322.
86. Jorm A. F. Jolley D. (1998) The incidence of dementia: a meta-analysis. Neurology 51, 728 733.
87. Katsel P. L., Davis K. L. Haroutunian V. (2005) Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int. Rev. Neurobiol. 63, 41 82.
88. Katzman R. (1986) Alzheimer's disease. N. Engl. J. Med. 314, 964 973. (Pubitemid 16129832)
89. Keilhoff G., Langnaese K., Wolf G. Fansa H. (2007) Inhibiting effect of minocycline on the regeneration of peripheral nerves. Dev. Neurobiol. 67, 1382 1395.
90. Kennedy D. W. Abkowitz J. L. (1997) Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90, 986 993.
91. Kim W. G., Mohney R. P., Wilson B., Jeohn G. H., Liu B. Hong J. S. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309 6316.
92. Kitazawa M., Oddo S., Yamasaki T. R., Green K. N. LaFerla F. M. (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 8843 8853.
93. Knobloch M. Mansuy I. M. (2008) Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol. Neurobiol. 37, 73 82.
94. Knopman D. S., Parisi J. E., Salviati A. et al. (2003) Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol. 62, 1087 1095.
95. Kurz T., Terman A., Gustafsson B. Brunk U. T. (2008) Lysosomes and oxidative stress in aging and apoptosis. Biochim. Biophys. Acta 1780, 1291 1303.
96. Lalancette-Hebert M., Gowing G., Simard A., Weng Y. C. Kriz J. (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596 2605.
97. Lavados M., Guillón M., Mujica M. C., Rojo L. E., Fuentes P. Maccioni R. B. (2008) Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. J. Alzheimers Dis. 13, 225 232.
98. Lawson L. J., Perry V. H., Dri P. Gordon S. (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151 170.
99. Laye S., Parnet P., Goujon E. Dantzer R. (1994) Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 27, 157 162.
100. Lebel-Binay S., Berger A., Zinzindohoue F., Cugnenc P., Thiounn N., Fridman W. H. Pages F. (2000) Interleukin-18: biological properties and clinical implications. Eur. Cytokine Netw. 11, 15 26.
101. Lee H. G., Ueda M., Zhu X., Perry G. Smith M. A. (2006) Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway? J. Neurosci. Res. 84, 1856 1861.
102. Lerner A. J., Hedera P., Koss E., Stuckey J. Friedland R. P. (1997) Delirium in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 11, 16 20.
103. Lesne S., Docagne F., Gabriel C. et al. (2003) Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J. Biol. Chem. 278, 18408 18418.
104. Letiembre M., Hao W., Liu Y., Walter S., Mihaljevic I., Rivest S., Hartmann T. Fassbender K. (2007) Innate immune receptor expression in normal brain aging. Neuroscience 146, 248 254.
105. LeWitt P. A. Taylor D. C. (2008) Protection against Parkinson's disease progression: clinical experience. Neurotherapeutics 5, 210 225.
106. Li Y., Liu L., Barger S. W. Griffin W. S. (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23, 1605 1611.
107. Lieb K., Engels S. Fiebich B. L. (2003) Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochem. Int. 42, 131 137.
108. Lim G. P., Yang F., Chu T. et al. (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model of Alzheimer's disease. J. Neurosci. 20, 5709 5714.
109. Lipton P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431 1568.
110. Liu P., Smith P. F., Appleton I., Darlington C. L. Bilkey D. K. (2004) Age-related changes in nitric oxide synthase and arginase in the rat prefrontal cortex. Neurobiol. Aging 25, 547 552.
111. Lobsiger C. S. Cleveland D. W. (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 10, 1355 1360.
112. Lopes K. O., Sparks D. L. Streit W. J. (2008) Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia 56, 1048 1060.
113. Lovell M. A., Xie C. Markesbery W. R. (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22, 187 194.
114. Lucin K. M. Wyss-Coray T. (2009) Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64, 110 122.
115. Lue L. F., Brachova L., Walker D. G., Shen Y. Rogers J. (1996) Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients. Neurobiol. Aging 17, 421 429.
116. Lue L. F., Rydel R., Brigham E. F. et al. (2001) Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35, 72 79.
117. Lukiw W. J. (2004) Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem. Res. 29, 1287 1297.
118. Luterman J. D., Haroutunian V., Yemul S., Ho L., Purohit D., Aisen P. S., Mohs R. Pasinetti G. M. (2000) Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch. Neurol. 57, 1153 1160.
119. Malm T. M., Koistinaho M., Pärepalo M., Vatanen T., Ooka A., Karlsson S. Koistinaho J. (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol. Dis. 18, 134 142.
120. Masters C. J. Crane D. I. (1995) On the role of the peroxisome in ontogeny, ageing and degenerative disease. Mech. Ageing Dev. 80, 69 83.
121. Mattson M. P. Magnus T. (2006) Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7, 278 294.
122. McCann S. M. (1997) The nitric oxide hypothesis of brain aging. Exp. Gerontol. 32, 431 440.
123. McCartney-Francis N. L. Wahl S. M. (2002) Dysregulation of IFN-γ signaling pathways in the absence of TGF-β1. J. Immunol. 169, 5941 5947.
124. McGeer P. L., Itagaki S., Tago H. McGeer E. G. (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79, 195 200.
125. McGeer P. L., Itagaki S., Boyes B. E. McGeer E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285 1291.
126. Meda L., Baron P. Scarlato G. (2001) Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins. Neurobiol. Aging, 22, 885 893.
127. Melnikova T., Savonenko A., Wang Q., Liang X., Hand T., Wu L., Kaufmann W. E., Vehmas A. Andreasson K. I. (2006) Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience 141, 1149 1162.
128. Melton L. M., Keith A. B., Davis S., Oakley A. E., Edwardson J. A. Morris C. M. (2003) Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA. Glia 44, 1 12.
129. Mittaud P., Labourdette G., Zingg H. Guenot-Di Scala D. (2002) Neurons modulate oxytocin receptor expression in rat cultured astrocytes: involvement of TGF-β and membrane components. Glia 37, 169 177.
130. Motta M., Imbesi R., Di Rosa M., Stivala F. Malaguarnera L. (2007) Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol. Lett. 114, 46 51.
131. Mouri H., Sakaguchi K., Sawayama T., Senoh T., Ohta T., Nishimura M., Fujiwara A., Terao M., Shiratori Y. Tsuji T. (2002) Suppressive effects of transforming growth factor-β1 produced by hepatocellular carcinoma cell lines on interferon - a production by peripheral blood mononuclear cells. Acta Med. Okayama 56, 309 315.
132. Nakanishi H. Wu Z. (2009) Microglia-aging: Roles of microglia lysosome- and mitochondria-derived reactive oxygen species in brain aging. Behav. Brain Res 201, 1 7 doi :.
133. Navarro A., Sánchez Del Pino M. J., Gómez C., Peralta J. L. Boveris A. (2002) Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R985 R992.
134. Neuroinflammation Working Group (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383 421.
135. Obregon D., Hou H., Bai Y. et al. (2008) CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation. Neurobiol. Dis. 29, 336 353.
136. Ojala J. O., Sutinen E. M., Salminen A. Pirttilä T. (2008) Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells. J. Neuroimmunol. 205, 86 93.
137. O'Keefe G. M., Nguyen V. T. Benveniste E. N. (2002) Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases. J. Neurovirol. 8, 496 512.
138. Pakkerberg B., Pelvig D., Marner L., Bundgaard M. J., Gundersen H. J., Nyengaard J. R. Regeur L. (2003) Aging and the human neocortex. Exp. Gerontol. 38, 95 99.
139. Perry V. H., Matyszak M. K. Fearn S. (1993) Altered antigen expression of microglia in the aged rodent CNS. Glia 7, 60 67.
140. Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G. Kokmen E. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303 308. (Pubitemid 29120227)
141. Pinteaux-Jones F., Sevastou I. G., Fry V. A., Heales S., Baker D. Pocock J. M. (2008) Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J. Neurochem. 106, 442 454.
142. Potter E. G., Cheng Y. Natale J. E. (2009) Deleterious effects of minocycline after in vivo target deprivation of thalamocortical neurons in the immature, metallothionein-deficient mouse brain. J. Neurosci. Res. 87, 1356 1368.
143. Prinz M., Kann O., Draheim H. J., Schumann R. R., Kettenmann H., Webwer J. R. Hanisch U. K. (1999) Microglial activation by components of gram-positive and -negative bacteria: distinct and common routes to the induction of ion channels and cytokines. J. Neuropathol. Exp. Neurol. 58, 1078 1089.
144. Qin L., Wu X., Block M. L., Liu Y., Breese G. R., Hong J. S., Knapp D. J. Crews F. T. (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453 462.
145. Quintanilla R. A., Orellana D. I., González-Billault C. Maccioni R. B. (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the Cdk5/p35 pathway. Exp. Cell Res. 295, 245 257.
146. Ramírez G., Toro R., Dobeli H. von Bernhardi R. (2005) Protection of rat primary hippocampal cultures from Abeta cytotoxicity by pro-inflammatory molecules is mediated by astrocytes. Neurobiol. Dis. 19, 243 254.
147. Ramírez G., Rey S. von Bernhardi R. (2008) Proinflammatory stimuli are needed for induction of microglial cell-mediated AβPP244-C and Aβ-neurotoxicity in hippocampal cultures. J. Alzheimers Dis. 15, 45 59.
148. Reuter-Lorenz P. A. Lustig C. (2005) Brain aging: reorganizing discoveries about the aging mind. Curr. Opin. Neurobiol. 15, 245 251.
149. Rodier F., Coppé J. P., Patil C. K., Hoeijmakers W. A., Muñoz D. P., Raza S. R., Freund A., Campeau E., Davalos A. R. Campisi J. (2009) Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973 979.
150. Rogers J. Lue L. F. (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39, 333 340.
151. Rogers J. T., Leiter L. M., McPhee J., Cahill C. M., Zhan S. S., Potter H. Nilsson L. N. (1999) Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274, 6421 6431.
152. Rogers J. T., Randall J. D., Cahill C. M. et al. (2002a) An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 277, 45518 45528.
153. Rogers J., Strohmeyer R., Kovelowski C. J. Li R. (2002b) Microglia and inflammatory mechanisms in the clearance of amyloid b peptide. Glia 40, 260 269.
154. Rojo L. E., Fernández J. A., Jiménez J. M., Maccioni A. A., Kuljis R. O. Maccioni R. B. (2009) Central nervous system inflammation and cholesterol metabolism alterations in the pathogenesis and diagnosis of Alzheimer disease, in Hypotheses and Research Milestones in Alzheimer's Disease (Maccioni R. B. Perry G., eds 125 137. Springer-Verlag. New York.
155. Rota E., Bellone G., Rocca P., Bergamasco B., Emanuelli G. Ferrero P. (2006) Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Neurol. Sci. 27, 33 39.
156. Sala G., Galimberti G., Canevari C., Raggi M. E., Isella V., Facheris M., Appollonio I. Ferrarese C. (2003) Peripheral cytokine release in Alzheimer patients: correlation with disease severity. Neurobiol. Aging 24, 909 914.
157. Salat D. H., Tuch D. S., Hevelone N. D., Fischl B., Corkin S., Rosas H. D. Dale A. M. (2005) Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann. N Y Acad. Sci. 1064, 37 49. (Pubitemid 43030947)
158. de Sampaio e Spohr T. C., Martinez R., da Silva E. F., Neto V. M. Gomes F. C. (2002) Neuro-Glia interaction effects on GFAP gene: a novel role for TGFβ1. Eur. J. Neurosci. 16, 2059 2069.
159. Saud K., Herrera-Molina R. von Bernhardi R. (2005) Pro- and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox. Res. 8, 277 287.
160. Schubert P., Morino T., Miyazaki H., Ogata T., Nakamura Y., Marchini C. Ferroni S. (2000) Cascading glia reactions: a common pathomecanism and its differentiated control by cyclic nucleotide signaling. Ann.N.Y.Acad.Sci. 903, 24 33.
161. Sheng J. G., Mrak R. E. Griffin W. S. (1997) Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. (Berl) 94, 1 5.
162. Sheng J. G., Bora S. H., Xu G., Borchelt D. R., Price D. L. Koliatsos V. E. (2003) Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133 145.
163. Shie F. S., Nivison M., Hsu P. C. Montine T. J. (2009) Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma. Curr. Med. Chem. 16, 643 651.
164. Shock N., Greulich R., Costa P., Andres R., Lakatta E., Arenberg D. Tobin J. (1984) Normal Human Aging: The Baltimore Longitudinal Study of Aging. US Department of Health and Human Services, Baltimore.
165. Sierra A., Gottfried-Blackmore A. C., McEwen B. S. Bulloch K. (2007) Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55, 412 424.
166. Simard A. R., Soulet D., Gowing G., Julien J. P. Rivest S. (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489 502.
167. Sohal R. S. Sohal B. H. (1991) Hydrogen peroxide release by mitochondria increases during aging. Mech. Ageing Dev. 57, 187 202.
168. Sparkman N. L. Johnson R. W. (2008) Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 15, 323 330.
169. Stark A. K., Toft M. H., Pakkenberg H., Fabricius K., Eriksen N., Pelvig
170. Stewart W. F., Kawas C., Corrada M. Metter E. J. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626 632.
171. Streit W. J. (2005) Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res. Brain Res. Rev. 48, 234 239.
172. Streit W. J., Mrak R. E. Griffin W. S. (2004a) Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation 1, 14 doi :.
173. Streit W. J., Sammons N. W., Kuhns A. J. Sparks D. L. (2004b) Dystrophic microglia in the aging human brain. Glia 45, 208 212.
174. Streit W. J., Braak H., Xue Q. S. Bechmann I. (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 118, 475 485.
175. Szweda P. A., Camouse M., Lundberg K. C., Oberley T. D. Szweda L. I. (2003) Aging, lipofuscin formation, and free radical-mediated inhibition of cellular proteolytic systems. Ageing Res. Rev. 2, 383 405.
176. Tarkowski E., Andreasen N., Tarkowski A. Blennow K. (2003) Intrathecal inflammation precedes development of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 74, 1200 1205.
177. Tichauer J., Saud K. von Bernhardi R. (2007) Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways. Neuroimmunomodulation 14, 168 174.
178. Town T., Nikolic V. Tan J. (2005) The microglial "activation" continuum: from innate to adaptive responses. J. Neuroinflammation 2, 24 doi :.
179. Town T., Laouar Y., Pittenger C., Mori T., Szekely C. A., Tan J., Duman R. S. Flavell R. A. (2008) Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 14, 681 687.
180. Townsend K. P., Town T., Mori T., Lue L. F., Shytle D., Sanberg P. R., Morgan D., Fernandez F., Flavell R. A. Tan J. (2005) CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur. J. Immunol. 35, 901 910.
181. Ueberham U., Ueberham E., Gruschka H. Arendt T. (2006) Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Eur. J. Neurosci. 24, 2327 2334.
182. Uversky V. N., Li J. Fink A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein. A possible molecular link between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276, 44284 44296.
183. Valente S. A., Fallon W. F., Jr., Alexander T. S., Tomas E. R., Evancho-Chapman M. M., Schmidt S. P., Gorski R., Pizov O., DeFine L. Clark A. J. (2009) Immunologic function in the elderly after injury-the neutrophil and innate immunity. J. Trauma 67, 968 974.
184. Vallières L. Sawchenko P. E. (2003) Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J. Neurosci. 23, 5197 5207.
185. Varin A. Gordon S. (2009) Alternative activation of macrophages: immune function and cellular biology. Immunobiology 214, 630 641 doi :.
186. Vijg J. Campisi J. (2008) Puzzles, promises and a cure for ageing. Nature 454, 1065 1071.
187. Vincent V. A., Tielders F. J. Van Dam A. M. (1997) Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor β. Glia 19, 190 198.
188. Weaver J. D., Huang M. H., Albert M., Harris T., Rowe J. W. Seeman T. E. (2002) Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59, 371 378.
189. Wegiel J., Wang K. C., Tarnawski M. Lach B. (2000) Microglial cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plaque degradation. Acta Neuropathol. (Berl.) 100, 356 364.
190. Weiskopf D., Weinberger B. Grubeck-Loebenstein B. (2009) The aging of the immune system. Transpl. Int. 22, 1041 1050.
191. Wyss-Coray T., Lin C., Yan F., Yu G. Q., Rohde M., McConlogue L., Masliah E. Mucke L. (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612 618.
192. Wyss-Coray T., Yan F., Lin A. H., Lambris J. D., Alexander J. J., Quigg R. J. Masliah E. (2002) Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc. Natl Acad. Sci. USA 99, 10837 10842.
193. Xu X., Zhan M., Duan W. et al. (2007) Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender. Genome Biol. 8, R234 doi :.
194. Xu H., Chen M., Manivannan A., Lois N. Forrester J. V. (2008) Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell. 7, 58 68.
195. Yamamoto K., Shimokawa T., Yi H., Isobe K., Kojima T., Loskutoff D. J. Saito H. (2002) Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am. J. Pathol. 161, 1805 1814.
196. Ye S. M. Johnson R. W. (1999) Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93, 139 148.
197. Ye S. M. Johnson R. W. (2001) An age-related decline in interleukin-1o may contribute to the increased expression of IL-6 in brain of aged mice. Neuroimmunomodulation 9, 183 192.
198. Yung R. L. Julius A. (2008) Epigenetics, aging and autoimmunity. Autoimmunity 41, 329 335.
199. Zahn J. M., Poosala S., Owen A. B. et al. (2007) AGEMAP: a gene expression database for aging in mice. PLoS Genet. 3, e201. doi
200. Zecca L., Gallorini M., Schünemann V., Trautwein A. X., Gerlach M., Riederer P., Vezzoni P. Tampellini D. (2001) Iron, neuromelanin and ferritin in substantia nigra of normal subjects at different ages. Consequences for iron storage and neurodegenerative disorders. J. Neurochem. 76, 1766 1773.
201. Zecca L., Youdim M. B., Riederer P., Connor J. R. Crichton R. R. (2004) Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863 873.
202. Zhu Y., Roth-Eichhorn S., Braun N., Culmsee C., Rami A. Krieglstein J. (2000) The expression of transforming growth factor beta 1 (TGF-β1) in hippocampal neurons: a temporary upregulated protein level after transient forebrain ischemia in the rat. Brain Res. 866, 286 298.
203. Zhu Y., Yang G. Y., Ahlemeyer B., Pang L., Che X. M. Culmsee C. (2002) Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22, 3898 3909.
204. Zhu X., Raina A. K., Perry G. Smith M. A. (2004) Alzheimer's disease: the two-hit hypothesis. Lancet Neurol. 3, 219 226.